Background:Diabetes has long been associated with maternal and perinatal mobidity and mortality. Infants of diabetic mothers (IDMs) have higher risks for serious problems during pregnancy, delivery and early neonatal period. Abnormal fetal metabolism during pregnancy which is complicated by maternal diabetes mellitus results in multiple neonatal sequelae. Objective: To study the clinical, metabolic and hematological profile in infants of diabetic mothers and to compare the neonatal outcome in gestational and pregestational (overt) diabetic mothers. Methods: 69 neonates born to diabetic mothers were enrolled in the study. Gestational age, birth weight, relevant perinatal history and examination findings were recorded. Blood samples were collected to perform relevant biochemical tests and managed as per unit protocol. Echocardiography and ultrasound abdomen was done routinely in all neonates. Results: Of the 69 neonates, 71.01% (49/69) were born to mothers with gestational diabetes mellitus (GDM), while the remaining 28.99% (20/69) were born to mothers with pregestational (overt) diabetes mellitus (PGDM). 53.63% (37/69) of mothers had poor glycemic control. Most of the neonates (73.91% -51/69) were delivered by cesarean section. 88.40% (61/69) of the babies were born at term. Majority of them (85.50% -59/69) were appropriate for gestational age with mean birth weight of 3.06±0.82kgs. Hypoglycemia was the most common metabolic abnormality seen in 73.91% (51/69) of neonates. Polycythemia was seen in 60.80% (42/69) of neonates. Congenital malformations were seen in 17.40% (12/69) of neonates, of which most of them had congenital heart disease. 11.60% (8/69) of the babies had suffered birth injuries. 5.80% (4/69) of neonates died in the early neonatal period. Occurrence of hypoglycemia, polycythemia, hyperbilirubinemia, congenital anomalies and birth injuries were significantly higher in infants born to mothers with GDM, whereas hypocalcemia and hypomagnesemia were significantly higher in infants of mothers with PGDM. Conclusions: Among the pregnancies complicated by diabetes, GDM continues to have a major contribution. Hypoglycemia and polycythemia remain the most common biochemical and hematological abnormality respectively. Congenital heart disease forms a major proportion of the congenital anomalies seen in IDMs. Mortality rate is higher in infants born to mothers with GDM.
Introduction
The prevalence of diabetes is increasing globally and India is no exception [1] . Diabetes mellitus (DM) is a chronic metabolic disorder due to either insulin deficiency (relative or absolute) or due to peripheral tissue resistance to the action of insulin [2] . Women are separated into those who were known to have diabetes before pregnancy as pregestational (PGDM) or overt, and those diagnosed during pregnancy as gestational (GDM) [3] . World Health Organization (WHO) has predicted that between 1995 and 2025, there will be a 35% increase in the world wide prevalence of diabetes [4] . These numbers also include GDM and should alert the physicians to direct special attention to this population, especially in developing countries [1] . Moreover, women born in Asian countries display the highest prevalence of GDM, with upto 17% of women likely to develop GDM in comparison to 4% of European and white American women [5, 6] . Before the discovery of insulin in 1921, diabetic women rarely reached reproductive age or survived pregnancy. Infact, pregnancy termination was recommended routinely for pregnant diabetics in view of high maternal and perinatal mortality [7] . Historically, mothers with GDM/PGDM have been at significantly greater risk for spontaneous abortions, intrauterine death and still birth, while the IDMs are at risk of several metabolic and hematological complications. Congenital malformations are also quite high in IDMs which contributes to significant perinatal morbidity and mortality. With the advent of insulin and oral hypoglycemic agents, outcome of pregnant women with diabetes has improved. But abnormal fetal metabolism during pregnancy complicated by maternal diabetes mellitus results in multiple neonatal sequelae, including abnormalities of growth, cardiorespiratory function, bilirubin metabolism and congenital anomalies [8] . The present study focuses on the outcome of neonates born to diabetic mothers with special reference to their clinical, metabolic and hematological profile.
Materials and Methods
Source of Data 69 neonates born to mothers diagnosed to have gestational/pregestational diabetes mellitus who met the inclusion criteria were selected. It was a hospital based, prospective observational cohort study conducted during the study period December 2011 to November 2013. Institutional ethical committee approval was taken before starting the study. The inclusion and exclusion criteria of the study were :
A. Inclusion criteria Singleton neonates born to diabetic mothers who were on treatment with oral hypoglycemic agents or insulin.
B. Exclusion criteria
• Neonates of diabetic mothers with medical complications such as chronic heart disease and chronic renal disease.
• Neonates of diabetic mothers with pregnancy induced hypertension (pre-eclampsia) or eclampsia.
• Twin neonates of diabetic mothers.
Method 69 neonates born to diabetic mothers who were admitted to the neonatal intensive care unit (NICU) and fulfilled the inclusion criteria were enrolled in the study. Informed written consent was obtained from parents/guardians prior to enrollment of their babies in the study. A predesigned and pretested proforma was used to collect data such as maternal age, parity, gestational age, previous abortions, still births and mode of delivery. Diabetic status and treatment was abstracted from the antenatal records and classified according to WHO guidelines. Diabetic mothers whose blood glucose levels was in the range of 75-115mg/dl throughout the day during pregnancy were considered to have good glycemic control, while those mothers with blood glucose levels outside this range (75-115mg/dl) were considered to have poor glycemic control. After the neonate was born, assessment was made on the basis of Apgar score to determine the need for resuscitation. After birth, the neonate was dried and placed under a preheated warmer. Baby was weighed using a digital weighing scale. Modified Ballard's score was used to assess the gestational age. Neonates were then screened for presence of major congenital anomalies. As per the unit protocol, all babies born to diabetic mothers were admitted to the NICU and hourly feeds were started. The first feed was usually given within 30 minutes of birth and babies were fed hourly for the first 6 hours and then two-hourly if blood glucose values were normal. Once normoglycemia was established on two-hourly feeds, babies were transferred back to the mother and started on breast feeds. Blood glucose levels were checked at 1, 2, 3, 6, 12, 24, 36 and 48 hours using a glucometer. If the glucometer value was ≤ 47mg/dl, plasma glucose estimation was performed for confirmation. Babies who remained hypoglycemic despite adequate feeds were started on intravenous (iv) dextrose infusion, Bolus iv dextrose was given only if the baby was symptomatic or blood glucose level was less than 25mg/dl. Blood samples for measuring packed cell volume (PCV) / hemoglobin, serum calcium and serum magnesium levels were also sent. Birth weight of the babies was plotted against gestational age and babies were classified as large, small or appropriate for gestational age. Hypoglycemia was defined as blood glucose level of ≤ 47mg/dl in any infant regardless of gestational age and whether or not symptoms were present. Polycythemia was defined as venous hematocrit (PCV) of more than 65% or a venous hemoglobin concentration in excess of 22gm/dl. Hypocalcemia was defined as total serum calcium less than 7mg/dl and hypomagnesemia as serum magnesium level of less than 1.7mg/dl. Hyperbilirubinemia was defined as serum bilirubin level of ≥ 15mg/dl. Large for gestational age (LGA) was defined as birth weight greater than the 90 th percentile and small for gestational age (SGA) as birth weight less than the 10 th percentile for that particular gestational age respectively. Babies with birth weight of more than 4000g were termed to be macrosomic. Babies born before 37 completed weeks of gestation were classified as preterm, while babies born with lethal/life threatening condition 
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requiring major surgery were considered to have a major congenital anomaly.
Statistical Methods
Descriptive statistical analysis was carried out in the present study. Results on continuous measurements were expressed as mean±standard deviation and as numbers (%) for categorical data. Significance was assessed at 5%. Chi square/Fisher exact test was used to find the significance of study parameters on categorical scale between two or more groups. Statistical software namely SAS 9.2, SPSS 15.0, Stata 10.1, MedCalc 9.0.1, Systat 12.0 and R environment version 2.11.1 were used for data analysis. Microsoft word and excel have been used to generate tables. A p value of < 0.05 was considered significant.
Results
Of the 75 neonates born to diabetic mothers during the study period December 2011 to November 2013, 6 neonates were excluded -2 neonates were still born and 4 neonates were born to diabetic mothers who had pregnancy induced hypertensiontherefore 69 neonates were included. Of the 69 neonates, 71.01% (49/69) were born to mothers with GDM, while the remaining 28.99% (20/69) were born to mothers with PGDM ( Table 1) . Majority of the neonates (57.98% -40/69) included in the study were males (Table 2 ). 53.63% (37/69) of neonates were born to mothers with poor glycemic control ( Table 3) . Lower segment cesarean section was the mode of delivery in 73.91% (51/69) of neonates (Table 4) . Mean birth weight was 3.06±0.82 kgs and most of the neonates (26.08% -18/69) weighed between 3.0 to 3.49 kgs (Table 5) . (Table 10 ). Ostium secundum ASD (50% -4/8) was the most common congenital heart disease among these neonates. Incidence of congenital malformations was significantly higher in IGDMs as compared to infants of mothers with PGDM (IPGDM) (p < 0.001) (Table 11) . Birth injuries were seen in 11.60% (8/69) of neonates. Cephalhematoma (37.5% -3/8) was the most commonly observed birth injury. Incidence of birth injuries was significantly higher in IGDMs as compared to IPGDMs (p < 0.001) (Table 12 ). 5.80% (4/69) of neonates included in the present study died. Mortality rate was significantly higher in IGDMs as compared to IPGDMs (Table 13 ). 
Discussion
Diabetes has long been associated with maternal and perinatal morbidity and mortality [7] . Infants of diabetic mothers (IDMs) may have higher risks for serious problems during pregnancy, delivery and early neonatal period. Problems during pregnancy include increased risk of abortions, still births and sudden intrauterine death. Abnormal fetal metabolism during pregnancy which is complicated by maternal diabetes results in multiple neonatal sequelae. Abnormalities of growth, metabolic and hematological status, cardiorespiratory function, bilirubin metabolism and congenital anomalies are frequently encountered in IDMs.
Causes of fetal and neonatal sequelae which are seen in babies born to diabetic mothers are multifactorial. However, majority of the perinatal complications can be traced to the effect of maternal glycemic control on the fetus and can be prevented by appropriate periconceptional and prenatal care [8] .
In the present study, clinical, metabolic and hematological profile of IDMs were studied. These parameters were also compared between age and gender matched IGDMs and IPGDMs and found significant differences in outcome of neonates. In the present study, most of the neonates were born to mothers with GDM. More than half of the mothers (37/69) had poor glycemic control. 90% of mothers with PGDM had good glycemic control in comparison to 28.57% of mothers with GDM. Glycemic control was better in mothers with PGDM may be due to the fact that, mothers with PGDM were diagnosed before pregnancy and were advised regarding the complications during pregnancy and possible neonatal outcome which enabled strict glycemic control with regular follow up. Most of the mothers with GDM were diagnosed late in pregnancy and were not on regular follow up. In the present study, majority of neonates were delivered by cesarean section. Most of the cesarean sections were done on emergency basis due to obstetric indications as a result of which the number of neonates delivered by cesarean section was slightly higher than those reported in previous studies [9, 10] . Most of these neonates were delivered at term and were appropriate for gestational age. Similar observation was seen in the study conducted by Mahmood CB et al [11] . However, in the study conducted by Ranade et al. [10] the proportion of preterm deliveries was higher and was probably because they included all diabetic mothers with coexisting medical complications like PIH, chronic heart and renal disease. In the present study, mean birth weight of the neonates was 3.06±0.82kgs (range 1.52kgs to 4.42kgs).
Similar observations were reported in the studies done previously [11] [12] [13] . Due to maternal hyperglycemia, there occurs fetal hyperglycemia as a result of which there is fetal hyperinsulinism. Since insulin is one of the important hormones affecting the intrauterine growth of the fetus, average weight of neonates born to mothers with DM is higher as compared to neonates born to otherwise healthy mothers. In the present study, incidence of hypoglycemia was significantly higher in IGDMs. This observation was in contrast to the results obtained in studies done earlier [11, 13] where the incidence of hypoglycemia was higher in IPGDMs. In the present study, most of the mothers with PGDM had good glycemic control which probably prevented fetal hyperinsulinism and significant hypoglycemia. It is also important to note that in the present study most of the hypoglycemic neonates were asymptomatic probably because of early introduction of frequent feeds. Most of the neonates had hypoglycemia by the end of 3 hours of birth. In the present study, incidence of hypocalcemia and hypomagnesemia was significantly higher in babies born to mothers with PGDM and this was probably because most of these babies had suffered perinatal asphyxia which resulted in lower calcium and magnesium levels. Similar observation was seen in the study conducted by Nili Firouzeh et al. [13] . In the present study, incidence of polycythemia and hyperbilirubinemia was significantly higher in IGDMs and all were managed conservatively. Similar observation was seen in the studies conducted by Mohsin et al. [12] and Nili Firouzeh et al. [13] . In the present study, incidence of congenital malformations was 17.40% and was slightly higher than those reported previously [9] [10] [11] 14] . This was probably because most of the neonates were born to mothers with GDM who had poor glycemic control. These congenital malformations can be attributed to hyperglycemia induced teratogenesis during the periconceptional and organogenesis period. Among the neonates with congenital malformations, majority of them had congenital heart disease of which ostium secundum ASD was the commonest. Thoracic meningomyelocoele was seen in two neonates. Birth injuries were seen in 8 neonates. Most of them were born to mothers with GDM and cephalhematoma was the commonest birth injury seen. All babies with birth injuries were delivered through vaginal route. In the present study, mortality rate was 5.8% and it was significantly higher in IGDMs. Of the 4 neonates who died, two had thoracic meningomyelocoele and developed sepsis, while the remaining two succumbed to the underlying congenital heart disease (PPHN).
Conclusion
Pregnant women with diabetes (Type1, Type 2 and gestational) are all at increased risk for adverse pregnancy outcomes. Among the pregnancies complicated by diabetes, GDM continues to have a major contribution. Adequate glycemic control before and during pregnancy is crucial to improve the outcome of neonates born to diabetic mothers. Hypoglycemia remains the most common biochemical abnormality followed by polycythemia and hyperbilirubinemia. Congenital heart disease remains a major contributor of all the congenital malformations seen in IDMs. Occurrence of morbidity and mortality was significantly more in IGDMs. Improving glycemic control of women during the periconceptional period and strict control of diabetes throughout pregnancy with regular follow up with obstetricians and physicians remains the only way of improving the maternal and neonatal outcome.
